Nuris Pharma Private Limited

Nuris Pharma Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN U24290MH2016PTC285232 Incorporated 29 August 2016 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Private Limited Company pharma
Revenue · FY 2025
₹48,300
▼ 70% YoY
Net profit · FY 2025
₹168
Net margin 0.3%
EBITDA · FY 2025
₹198
EBITDA margin 0.4%
Authorised capital
₹2 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
10 yrs
Est. 2016
Directors on board
2
As per MCA filings
Last financials
Mar 2025
Balance sheet date

About Nuris Pharma Private Limited

Data last updated:

Nuris Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 29 August 2016 and has been in existence for over 10 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24290MH2016PTC285232.

The company has an authorised share capital of ₹2 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Babita Sanjay Bhandari and Trupti Jayant Gosalia.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Lower Level – 6 L L – 6 Hi Life P.M.Street Santacruz West, Mumbai, Maharashtra, India – 400054.

As per the financials filed for FY 2025, the company reported a revenue of ₹48,300, a decline of 70% compared to the previous year. For the same year it recorded a net profit of ₹168 (net margin 0.3%) and EBITDA of ₹198 (EBITDA margin 0.4%). Revenue has grown at a compounded annual rate (CAGR) of 33% over three years and 10% over five years.

The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U24290MH2016PTC285232
Registration Number 285232
Incorporation Date 29 August 2016
ROC Mumbai
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant

Contact details

Nuris Pharma Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address is in the company report.

  • Email
  • Registered Address
    Lower Level – 6 L L – 6 Hi Life P.M.Street Santacruz West, Mumbai, Maharashtra, India – 400054
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of Nuris Pharma Private Limited, buy the company report.

Comprehensive company report
Nuris Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Nuris Pharma is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturing21Manufacture of basic pharmaceutical products and pharmaceutical preparations

To see the full business activity and turnover split of Nuris Pharma Private Limited, buy the company report.

Financials of Nuris Pharma Private Limited

FY 2025 filings available

Nuris Pharma Private Limited reported revenue of ₹48,300 (down 70% YoY) for FY 2025.

Revenue · FY 2025
₹48,300 ▼ 70%
Net profit · FY 2025
₹168 margin 0.3%
EBITDA · FY 2025
₹198 margin 0.4%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 70%
3 years · compounded
▼ 33%
5 years · compounded
▲ 10%
EBITDA CAGR growth
1 year
▼ 35%
3 years · compounded
▲ 38%
5 years · compounded
▼ 38%

Revenue fell 70% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 10%. EBITDA fell 35% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹198
Profit Before Tax
Tax Expense
Net Profit (PAT)₹168
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin0.4%
Net Profit Margin0.3%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Nuris Pharma Private Limited, buy the company report.

Board of directors of Nuris Pharma Private Limited

Nuris Pharma has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Babita Sanjay BhandariDirector02 Feb 20242 Years 9 MonthsCurrent
Trupti Jayant GosaliaDirector29 Aug 201610 Years 2 MonthsCurrent

Auditor

Nuris Pharma Private Limited is audited by M H DALAL & ASSOCIATES for the financial year 2020.

Auditor firmFinancial yearFirm registration number
M H DALAL & ASSOCIATESFY 2020112449W

Shareholding

The shareholding of Nuris Pharma Private Limited is on record for 3 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2020FY 2019FY 2017
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Nuris Pharma Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Nuris Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

No GST registration is on our record for Nuris Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Nuris Pharma Private Limited has 4 board changes on record since 2016: 2 appointments and 2 cessations. The latest: Babita Sanjay Bhandari ceased to be Additional Director on 29 Sep 2024.

AGM
Nuris Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Nuris Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Ceased
Babita Sanjay Bhandari ceased to be Additional Director.
Appointed
Babita Sanjay Bhandari was appointed as Director.
Ceased
Smita Tarun Modi ceased to be Director.
Appointed
Trupti Jayant Gosalia was appointed as Director.
Incorporation
29 Aug 2016
Nuris Pharma Private Limited was registered on 29 Aug 2016 with Roc Mumbai I & aged 10 years 2 months as per MCA records.

Frequently asked questions

Nuris Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 29 August 2016 (10+ years old) and is registered under CIN U24290MH2016PTC285232.

Nuris Pharma has 2 current directors:

The latest financial statements of Nuris Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.

The CIN (Corporate Identification Number) of Nuris Pharma is U24290MH2016PTC285232. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Nuris Pharma was incorporated on 29 August 2016, making it 10+ years old. It is registered with the Registrar of Companies, Mumbai.

Babita Sanjay Bhandari ceased to be Additional Director on 29 Sep 2024. Babita Sanjay Bhandari was appointed as Director on 02 Feb 2024. Smita Tarun Modi ceased to be Director on 16 Dec 2023. Nuris Pharma has 4 board changes on record in total.

The registered office of Nuris Pharma is at Lower Level – 6 L L – 6 Hi Life P.M.Street Santacruz West, Mumbai, Maharashtra, India – 400054.

Nuris Pharma operates in the pharma industry, in the pharmaceutical retailers and distributors segment.

The compliance status of Nuris Pharma is compliant as of 21 August 2026. The company is actively filing with the Registrar of Companies.

Nuris Pharma can be reached at its registered office: Lower Level – 6 L L – 6 Hi Life P.M.Street Santacruz West, Mumbai, Maharashtra, India – 400054.